DENINTUZUMAB MAFODOTIN

UNII: H5324S1M7H
Preferred Substance Name: DENINTUZUMAB MAFODOTIN

1399672-02-6
DENINTUZUMAB MAFODOTIN [INN]
DENINTUZUMAB MAFODOTIN [USAN]
DENINTUZUMAB MAFODOTIN [WHO-DD]
IMMUNOGLOBULIN G1-KAPPA AURISTATIN F CONJUGATE, ANTI-(HOMOSAPIENS CD19 (B LYMPHOCYTE SURFACE ANTIGEN B4, LEU-12)), HUMANIZED MONOCLONAL ANTIBODY
SGN-19A
SGNCD19A
SGN-CD19A

Common Chemistry
i
Inxight Drugs
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

DENINTUZUMAB MAFODOTIN

Synonyms and Mappings

Resources

Note